New 340B Rule Lets Feds Fine Drugmakers for Overcharges

by admin | January 4, 2017 4:24 pm

January 4, 2017—The Department of Health and Human Services published a 340B program final rule today implementing fines for drug manufacturers that knowingly and intentionally overcharge safety-net healthcare providers. The rule also sets standards for calculating 340B ceiling prices.  

You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register[1].    Already registered? Click here to login[2]. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)

Follow | Share | Like
  1. Click here to register:
  2. Click here to login:
  3. [Image]:
  4. :

Source URL: